Wayfair is fairly upfront about its returns policy—even the parts that may seem unfair to customers. If you return an item, ...

Q2 2025 Earnings Call Transcript August 1, 2025 IRadimed Corporation reports earnings inline with expectations. Reported EPS ...

Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

Present results of the TACTIVE-N trial, a Phase 2 clinical trial of neoadjuvant vepdegestrant, in a mini oral session at European Society for Medical Oncology 2025 Congress (ClinicalTrials.gov ...

Detailed price information for Obsidian Energy Ltd (OBE-T) from The Globe and Mail including charting and trades.

Many retail chains disguise clearance as “limited time” offers. Learn how to spot these tricks and save money with practical ...

Launch preparations underway ahead of U.S. PDUFA goal date of September 7, 2025. The sNDA for PYRUKYND for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent ...

PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securitiesPYRUKYND sNDA for thalassemia under ...

Australia's spy boss warns foreign espionage is costing the nation more than $12 billion dollars a year; Political leaders head to the Northern Territory as the Garma Festival marks 25 years; And ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which Apel ...

As of June 30, 2025, Apellis had $370.0 million in cash and cash equivalents, compared to $411.3 million in cash and cash equivalents as of December 31, 2024. Apellis anticipates its cash, combined ...

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.